Skip to Main content
Number of documents

52

CV


 

Luc CAMOIN, PhD, 57

 

CURSUS

Habilitation to supervise research (HDR) at University Paris Descartes

PhD in Biochemistry at University Denis Diderot, Paris, France (Genome and Proteome)

DEA – Equivalent of a Master of Science on Organic Chemistry at Montpellier University, France

Degree in Chemistry and Chemical Engineering at the National School of Chemistry of Montpellier, France - l'Ecole Nationale Supérieure de Chimie de Montpellier ENSCM

 

FONCTIONS

Since 2010 Member of the Marseille Proteomics Facility (Centre de recherche en Cancérologie de Marseille ; CRCM, Institut Paoli Calmettes ; IPC)

2007-2009 Leader of the University Paris Descartes Proteomics Platform

2002-2007 Group Leader of the Proteomic Laboratory (Institut Cochin)

2001-2002 Codirector of the Functional Proteomic Research Team (Institut Cochin de Génétique Moléculaire, Department of Cellular Biology)

1990-2001 Group Leader of the Protein Structure Research Team in the Molecular Immuno-Pharmacology laboratory (Centre National de la Recherche Scientifique, CNRS)

1990- Research Engineer at INSERM (Institut National de la Santé et de la Recherche Médicale)

1987-1990 Research Engineer at the Pasteur Institute in Paris Responsable for creation of the protein microsequencing laboratory (3 people)

1985-1986 Assistant Engineer at the Military laboratory for the French Navy SECLF (Station d'Essais des Combustibles et Lubrifiants de la Flotte) (10 people)

1984-1985 Engineer Responsible for project at the French oil society TOTAL. Study of the use of Inductively Coupled Plasmas in analytical atomic spectrometry for metals analysis in petrochemistry

 

ACTIVITES LINKED TO SCIENTIFIC RESEARCH

Organization of a 4 days courses every 2 years for the INSERM entitled " Proteomics in all its states - An Introduction to proteomics ", since 2016, Marseille, France ( 20 people).

Organisation of one weeks courses for INSERM Introduction to proteomic tools, (2004-2010), Paris, France (20 people).

Organization of a workshop multi-institution (CNRS-INSERM-INRA) entitled "Contribution of the quantitative proteomics for the discovery of biomarkers", in June, 2014 (80 people), Sète, France.

Organisation of a 3 days courses every 2 years for INSERM  entitled « Interactome ; Biochemical and Biophysical approches », since 2011, Marseille, France (20 personnes)

Organization of a workshop multi-institution (CNRS-INSERM-INRA) "Interactomique: contributions of the mass spectrometry and proteomics", in June, 2012. La Grande-Motte, France (80 people).

Organisation of the workshop 146 for INSERM entitled Proteomic Analysis: New approaches to studying protein-protein interactions, 10-12 September 2003, La Londe-Les-Maures, Toulon, France

 

Member of the Board of the French proteomic society (2011-2017)

Member of the French committee of the pharmacopoeia - Biological products and innovative therapies (since 2014)

Member od the scientific advisory board of the “Pole Proteome de Montpellier” since 2011

 

PUBLICATIONS 78 Publications and 4 patents

 

Selected recent publications

• Activation peptide of the coagulation factor XIII (AP-F13A1) as a new biomarker for the screening of colorectal cancer (2018) Peltier, J., Roperch, J.P., Audebert, S., Borg, J.P., and Camoin, L. Clin Proteomics ; 15, 15.

• Cyclipostins and cyclophostin analogs inhibit the antigen 85C from Mycobacterium tuberculosis both in vitro and in vivo (2018) Viljoen, A., Richard, M., Nguyen, P.C., Fourquet, P., Camoin, L., Paudal, R.R., Gnawali, G.R., Spilling, C.D., Cavalier, J.F., Canaan, S., et al. J Biol Chem ; 293, 2755-2769.

• Early prognostic factors in septic shock cancer patients: a prospective study with a proteomic approach (2018) Mokart, D., Saillard, C., Zemmour, C., Bisbal, M., Sannini, A., Chow-Chine, L., Brun, J.P., Faucher, M., Boher, J.M., Toiron, Y., Chabannon, C., Borg, J. P., Goncalves, A. et Camoin, L. Acta Anaesthesiol Scand ; 62, 493-503.

• How may targeted proteomics complement genomic data in breast cancer? (2017)Guerin M, Gonçalves A, Toiron Y, Baudelet E, Audebert S, Boyer JB, Borg JP, Camoin L. Expert Rev Proteomics; 14(1):43-54.

• Fibronectin-guided migration of carcinoma collectives (2017) Gopal S, Veracini L, Grall D, Butori C, Schaub S, Audebert S, Camoin L, Baudelet E, Radwanska A, Beghelli-de la Forest Divonne S, Violette SM, Weinreb PH, Rekima S, Ilie M, Sudaka A, Hofman P, Van Obberghen-Schilling E. Nat Commun; 8:14105.

• Bonacci, T., Audebert, S., Camoin, L., Baudelet, E., Iovanna, J.L., and Soubeyran, P. (2017). Regulation of NUB1 Activity through Non-Proteolytic Mdm2-Mediated Ubiquitination. PLoS One ; 12 e0169988.

• Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family (2016) Peltier J, Roperch JP, Audebert S, Borg JP, Camoin L. J Proteomics; 148:139-48

• The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells (2016) Roncagalli R, Cucchetti M, Jarmuzynski N, Grégoire C, Bergot E, Audebert S, Baudelet E, Menoita MG, Joachim A, Durand S, Suchanek M, Fiore F, Zhang L, Liang Y, Camoin L, Malissen M, Malissen B. J Exp Med; 213(11):2437-2457.

• Identification of New Mechanisms of Cellular Response to Chemotherapy by Tracking Changes in Post-Translational Modifications by Ubiquitin and Ubiquitin-Like Proteins (2014) Bonacci T, Audebert S, Camoin L, Baudelet E, Bidaut G, Garcia M, Witzel, II, Perkins ND, Borg JP, Iovanna JL, Soubeyran P: J Proteome Res; 13(5):2478-94

• Glial-cell-mediated re-induction of the blood-brain barrier phenotype in brain capillary endothelial cells: a differential gel electrophoresis study (2013) Deracinois B, Pottiez G, Chafey P, Teerlink T, Camoin L, Davids M, Broussard C, Couraud PO, Dehouck MP, Cecchelli R, Karamanos Y, Flahaut C. Proteomics; 13(7):1185-1199


Journal articles50 documents

  • Francois Iv, Carla Silva Martins, Gerard Castro-Linares, Cyntia Taveneau, Pascale Barbier, et al.. Insights into animal septins using recombinant human septin octamers with distinct SEPT9 isoforms. Journal of Cell Science, Company of Biologists, 2021, 134 (15), pp.jcs258484. ⟨10.1242/jcs.258484⟩. ⟨hal-03119193⟩
  • Florent Colin, Kristine Schauer, Ali Hamiche, Pierre Martineau, Jean-Paul Borg, et al.. The NANOTUMOR consortium - Towards the Tumor Cell Atlas. Biology of the Cell, Wiley, 2021, 113 (6), pp.272-280. ⟨10.1111/boc.202000135⟩. ⟨hal-03169719⟩
  • A. Takedachi, E. Despras, S. Scaglione, R. Guérois, J. Guervilly, et al.. SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations. Nature Structural and Molecular Biology, Nature Publishing Group, 2020, 27 (5), pp.438-449. ⟨10.1038/s41594-020-0419-3⟩. ⟨hal-02995970⟩
  • A. Takedachi, E. Despras, S. Scaglione, R. Guérois, J. Guervilly, et al.. Publisher Correction: SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations. Nature Structural and Molecular Biology, Nature Publishing Group, 2020, 27 (6), pp.604-604. ⟨10.1038/s41594-020-0447-z⟩. ⟨hal-02997075⟩
  • A. Takedachi, E. Despras, S. Scaglione, R. Guérois, J. Guervilly, et al.. SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations. Nature Structural and Molecular Biology, Nature Publishing Group, 2020, 27 (5), pp.438-449. ⟨10.1038/s41594-020-0419-3⟩. ⟨hal-03079782⟩
  • Wenjun Lan, Patricia Santofimia-Castaño, Mirna Swayden, Yi Xia, Zhengwei Zhou, et al.. ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents. JCI Insight, American Society for Clinical Investigation, 2020, 5 (18), ⟨10.1172/jci.insight.138117⟩. ⟨hal-02992672⟩
  • Sylvie Thuault, Claire Mamelonet, Joëlle Salameh, Kevin Ostacolo, Brice Chanez, et al.. A proximity-labeling proteomic approach to investigate invadopodia molecular landscape in breast cancer cells. Scientific Reports, Nature Publishing Group, 2020, 10 (1), ⟨10.1038/s41598-020-63926-4⟩. ⟨hal-03174369⟩
  • Rania Ghossoub, Marion Chéry, Stéphane Audebert, Raphael Leblanc, Antonio Luis Egea-Jimenez, et al.. Tetraspanin-6 negatively regulates exosome production. Proceedings of the National Academy of Sciences of the United States of America , National Academy of Sciences, 2020, pp.201922447. ⟨10.1073/pnas.1922447117⟩. ⟨hal-02496544⟩
  • Marie-Josée Santoni, Rudra Kashyap, Luc Camoin, Jean-Paul Borg. The Scribble family in cancer: twentieth anniversary. Oncogene, Nature Publishing Group, 2020, 39 (47), pp.7019-7033. ⟨10.1038/s41388-020-01478-7⟩. ⟨hal-03048143⟩
  • Sylvie Thuault, Claire Mamelonet, Joëlle Salameh, Kevin Ostacolo, Brice Chanez, et al.. A proximity-labeling proteomic approach to investigate invadopodia molecular landscape in breast cancer cells. Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.6787. ⟨10.1038/s41598-020-63926-4⟩. ⟨inserm-02859860⟩
  • Marie-Josée Santoni, Rudra Kashyap, Luc Camoin, Jean-Paul Borg. The Scribble family in cancer: twentieth anniversary. Oncogene, Nature Publishing Group, 2020, 39, pp.7019-7033. ⟨10.1038/s41388-020-01478-7⟩. ⟨hal-03087102⟩
  • Jean-François Cavalier, Christopher Spilling, Thierry Durand, Luc Camoin, Stéphane Canaan. Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery. European Journal of Medicinal Chemistry, Elsevier, 2020, pp.112908. ⟨10.1016/j.ejmech.2020.112908⟩. ⟨hal-02990084⟩
  • Abdeldjalil Madani, Ivy Mallick, Alexandre Guy, Céline Crauste, Thierry Durand, et al.. Dissecting the antibacterial activity of oxadiazolone-core derivatives against Mycobacterium abscessus. PLoS ONE, Public Library of Science, 2020, 15 (9), pp.e0238178. ⟨10.1371/journal.pone.0238178⟩. ⟨hal-02950695⟩
  • Suzy Bulot, Stéphane Audebert, Laetitia Pieulle, Farida Seduk, Emilie Baudelet, et al.. Clustering as a Means To Control Nitrate Respiration Efficiency and Toxicity in Escherichia coli. mBio, American Society for Microbiology, 2019, 10 (5), ⟨10.1128/mBio.01832-19⟩. ⟨hal-02347742⟩
  • Elia Torres-Gutiérrez, Yobana Pérez-Cervera, Luc Camoin, Edgar Zenteno, Moyira Osny Aquino-Gil, et al.. Identification of O-Glcnacylated Proteins in Trypanosoma cruzi. Frontiers in Endocrinology, Frontiers, 2019, 10, pp.199. ⟨10.3389/fendo.2019.00199⟩. ⟨hal-02533352⟩
  • Maria Katsogiannou, Jean-Baptiste Boyer, Alberto Valdeolivas, Elisabeth Remy, Laurence Calzone, et al.. Integrative proteomic and phosphoproteomic profiling of prostate cell lines. PLoS ONE, Public Library of Science, 2019, 14 (11), pp.e0224148. ⟨10.1371/journal.pone.0224148⟩. ⟨hal-02343995⟩
  • Luc Camoin, Jean-Paul Borg, Avais Daulat, Pascal Finetti, Diego Revinski, et al.. ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer. British Journal of Cancer, Cancer Research UK, 2019, 120 (9), pp.931-940. ⟨10.1038/s41416-019-0448-z⟩. ⟨hal-02145896⟩
  • Avais Daulat, Mônica Silveira Wagner, Alexandra Walton, Emilie Baudelet, Stéphane Audebert, et al.. The Tumor Suppressor SCRIB is a Negative Modulator of the Wnt/β‐Catenin Signaling Pathway. Proteomics, Wiley-VCH Verlag, 2019, 19 (21-22), pp.1800487. ⟨10.1002/pmic.201800487⟩. ⟨hal-02518664⟩
  • Sophia Murat El Houdigui, Christelle Adam-Guillermin, Giovanna Loro, Caroline Arcanjo, Sandrine Frelon, et al.. A systems biology approach reveals neuronal and muscle developmental defects after chronic exposure to ionising radiation in zebrafish. Scientific Reports, Nature Publishing Group, 2019, 9 (1), ⟨10.1038/s41598-019-56590-w⟩. ⟨hal-02527559⟩
  • Avais Daulat, Pascal Finetti, Diego Revinski, Mônica Silveira Wagner, Luc Camoin, et al.. ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer. British Journal of Cancer, Cancer Research UK, 2019, 120 (9), pp.931-940. ⟨10.1038/s41416-019-0448-z⟩. ⟨hal-02518543⟩
  • Abdeldjalil Madani, Jeremy Ridenour, Benjamin Martin, Rishi Paudel, Anosha Abdul Basir, et al.. Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of Mycobacterium abscessus. ACS Infectious Diseases, American Chemical Society, 2019, ⟨10.1021/acsinfecdis.9b00172⟩. ⟨hal-02276160⟩
  • Mirna Swayden, Aurélie Dobric, Yolande Berthois, Hugo Villalba, Stéphane Audebert, et al.. Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations. Journal of visualized experiments : JoVE, JoVE, 2019, ⟨10.3791/60402⟩. ⟨inserm-02439827⟩
  • Mirna Swayden, George Alzeeb, Rawand Masoud, Yolande Berthois, Stéphane Audebert, et al.. PML hyposumoylation is responsible for the resistance of pancreatic cancer. FASEB Journal, Federation of American Society of Experimental Biology, 2019, 33 (11), pp.12447-12463. ⟨10.1096/fj.201901091R⟩. ⟨inserm-02439811⟩
  • Sylvain Garciaz, Lia N’guyen Dasi, Pascal Finetti, Christine Chevalier, Julien Vernerey, et al.. Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation. Clinical Epigenetics, BioMed Central, 2019, 11 (1), ⟨10.1186/s13148-019-0738-6⟩. ⟨hal-02322283⟩
  • Mathilde Guérin, Anthony Gonçalves, Yves Toiron, Emilie Baudelet, Matthieu Pophillat, et al.. Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer. Oncotarget, Impact journals, 2018, 9 (73), pp.33762-33777. ⟨10.18632/oncotarget.26031⟩. ⟨hal-02145636⟩
  • D. Mokart, C. Saillard, C. Zemmour, M. Bisbal, A. Sannini, et al.. Early prognostic factors in septic shock cancer patients: a prospective study with a proteomic approach. Acta Anaesthesiologica Scandinavica, Wiley, 2018, 62 (4), pp.493-503. ⟨10.1111/aas.13060⟩. ⟨hal-01780657⟩
  • Loïc Lebellec, François Bertucci, Emmanuelle Tresch-Bruneel, Isabelle Ray-Coquard, Axel Le Cesne, et al.. Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial. BMC Cancer, BioMed Central, 2018, 18 (1), pp.963. ⟨10.1186/s12885-018-4828-1⟩. ⟨inserm-02050851⟩
  • Julien Peltier, Jean-Pierre Roperch, Stéphane Audebert, Jean-Paul Borg, Luc Camoin. Activation peptide of the coagulation factor XIII (AP-F13A1) as a new biomarker for the screening of colorectal cancer. Clinical Proteomics, BioMed Central, 2018, 15 (1), ⟨10.1186/s12014-018-9191-3⟩. ⟨hal-01783956⟩
  • Avais Daulat, Tania Puvirajesinghe, Luc Camoin, Jean-Paul Borg. Mapping Cellular Polarity Networks Using Mass Spectrometry-based Strategies. Journal of Molecular Biology, Elsevier, 2018, 430 (19), pp.3545-3564. ⟨10.1016/j.jmb.2018.05.023⟩. ⟨hal-02145872⟩
  • Albertus Viljoen, Matthias Richard, Phuong Chi Nguyen, Patrick Fourquet, Luc Camoin, et al.. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from Mycobacterium tuberculosis both in vitro and in vivo. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2018, 293 (8), pp.2755-2769. ⟨10.1074/jbc.RA117.000760⟩. ⟨hal-01770061⟩
  • Phuong Chi Nguyen, Vincent Delorme, Anaïs Benarouche, Alexandre Guy, Valérie Landry, et al.. Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis. Bioorganic Chemistry, Elsevier, 2018, 81, pp.414-424. ⟨10.1016/j.bioorg.2018.08.025⟩. ⟨hal-01875577⟩
  • Phuong Chi Nguyen, van Son Nguyen, Benjamin Martin, Patrick Fourquet, Luc Camoin, et al.. Biochemical and Structural Characterization of TesA, a Major Thioesterase Required for Outer-Envelope Lipid Biosynthesis in Mycobacterium tuberculosis. Journal of Molecular Biology, Elsevier, 2018, 430 (24), pp.5129-5136. ⟨10.1016/j.jmb.2018.09.017⟩. ⟨hal-01894053⟩
  • Barbara Deracinois, Luc Camoin, Matthias Lambert, Jean -Baptiste Boyer, Erwan Dupont, et al.. O-GlcNAcylation site mapping by (azide-alkyne) click chemistry and mass spectrometry following intensive fractionation of skeletal muscle cells proteins. Journal of Proteomics, Elsevier, 2018, 186, pp.83-97. ⟨10.1016/j.jprot.2018.07.005⟩. ⟨hal-02143569⟩
  • Ali Badache, Habib Bouguenina, Danièle Salaün, Aurélie Mangon, Leslie Muller, et al.. EB1-binding–myomegalin protein complex promotes centrosomal microtubules functions. Proceedings of the National Academy of Sciences of the United States of America , National Academy of Sciences, 2017, 114 (50), pp.E10687 - E10696. ⟨10.1073/pnas.1705682114⟩. ⟨hal-01765369⟩
  • Thomas Bonacci, Stéphane Audebert, Luc Camoin, Emilie Baudelet, Juan-Lucio Iovanna, et al.. Regulation of NUB1 Activity through Non- Proteolytic Mdm2-Mediated Ubiquitination. PLoS ONE, Public Library of Science, 2017. ⟨hal-01787875⟩
  • Mathilde Guérin, Anthony Gonçalves, Yves Toiron, Emilie Baudelet, Stéphane Audebert, et al.. How may targeted proteomics complement genomic data in breast cancer?. Expert Review of Proteomics, Taylor & Francis, 2017, 14 (1), pp.43-54. ⟨10.1080/14789450.2017.1256776⟩. ⟨hal-01489501⟩
  • Sandeep Gopal, Laurence Veracini, Dominique Grall, Catherine Butori, Sébastien Schaub, et al.. Fibronectin-guided migration of carcinoma collectives. Nature Communications, Nature Publishing Group, 2017, 8, pp.14105. ⟨10.1038/ncomms14105⟩. ⟨hal-01783964⟩
  • Loic Lebellec, François Bertucci, Emmanuelle Tresch-Bruneel, Emmanuelle Bompas, Yves Toiron, et al.. Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO). Oncotarget, Impact journals, 2016, Oncotarget, 7 (45), pp.73984-73994. ⟨10.18632/oncotarget.12172⟩. ⟨hal-01453300⟩
  • Peltier Julien, Jean P. Roperch, Stephane Audebert, Jean-Paul Borg, Luc Camoin. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family. Journal of Proteomics, Elsevier, 2016, ⟨10.1016/j.jprot.2016.07.031⟩. ⟨inserm-01369621⟩
  • Romain Roncagalli, Margot Cucchetti, Nicolas Jarmuzynski, Claude Grégoire, Elise Bergot, et al.. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells. Journal of Experimental Medicine, Rockefeller University Press, 2016, 213 (11), pp.2437-2457. ⟨10.1084/jem.20160579⟩. ⟨hal-01455791⟩
  • Christophe Fraisier, Raquel Rodrigues, Vinh Vu Hai, Maya Belghazi, Stéphanie Bourdon, et al.. Hepatocyte pathway alterations in response to in vitro Crimean Congo hemorrhagic fever virus infection.. Virus Res, 2014, 179, pp.187-203. ⟨10.1016/j.virusres.2013.10.013⟩. ⟨hal-00972351⟩
  • Barbara Deracinois, Gwënaël Pottiez, Philippe Chafey, Tom Teerlink, Luc Camoin, et al.. Glial-cell-mediated re-induction of the blood-brain barrier phenotype in brain capillary endothelial cells: A differential gel electrophoresis study. Proteomics, Wiley-VCH Verlag, 2013, 13 (7), pp.1185-1199. ⟨10.1002/pmic.201200166⟩. ⟨hal-02515850⟩
  • Edwige Belotti, Tania M. Puvirajesinghe, Stéphane Audebert, Emilie Baudelet, Luc Camoin, et al.. Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes. PLoS ONE, Public Library of Science, 2012, 7 (9), pp.e46213. ⟨10.1371/journal.pone.0046213⟩. ⟨hal-01447666⟩
  • J. Chamot-Rooke, G. Mikaty, C. Malosse, M. Soyer, A. Dumont, et al.. Posttranslational modification of pili upon cell contact triggers N. meningitidis dissemination.. Science, American Association for the Advancement of Science, 2011, 331 (6018), pp.778-782. ⟨10.1126/science.1200729⟩. ⟨hal-00904588⟩
  • Guillaume Bussone, Hanadi Dib, Mathieu Tamby, Cedric Broussard, Christian Federici, et al.. Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor beta pathway in patients with systemic sclerosis.. Arthritis Research and Therapy, BioMed Central, 2011, 13 (3), pp.R74. ⟨10.1186/ar3336⟩. ⟨inserm-00606111⟩
  • Andréa Toma, Taghrid Laïka, Samy Haddouk, Sandrine Luce, Jean-Paul Briand, et al.. Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes.. Diabetes, American Diabetes Association, 2009, 58 (2), pp.394-402. ⟨10.2337/db08-0599⟩. ⟨hal-00357419⟩
  • Pascal Maurice, Avais Daulat, Cédric Broussard, Julien Mozo, Guilhem Clary, et al.. A Generic Approach for the Purification of Signaling Complexes That Specifically Interact with the Carboxyl-terminal Domain of G Protein-coupled Receptors. Molecular and Cellular Proteomics, American Society for Biochemistry and Molecular Biology, 2008, ⟨10.1074/mcp.M700435-MCP200⟩. ⟨hal-02348044⟩
  • T. Boukpessi, S. Menashi, L. Camoin, J. M. Tencate, M. Goldberg, et al.. The effect of stromelysin-1 (MMP-3) on non-collagenous extracellular matrix proteins of demineralized dentin and the adhesive properties of restorative resins.. Biomaterials, Elsevier, 2008, epub ahead of print. ⟨10.1016/j.biomaterials.2008.07.035⟩. ⟨hal-00319853⟩
  • Julia Chamot-Rooke, B. Rousseau, F. Lanternier, G. Mikaty, E. Mairey, et al.. Alternative Neisseria spp. type IV pilin glycosylation with a glyceramido acetamido trideoxyhexose residue.. Proceedings of the National Academy of Sciences of the United States of America , National Academy of Sciences, 2007, 104 (37), pp.14783-14788. ⟨10.1073/pnas.0705335104⟩. ⟨hal-00904602⟩
  • Eduardo Osinaga, Diana Tello, Carlos Batthyany, Mario Bianchet, Gisele Tavares, et al.. Amino acid sequence and three-dimensional structure of the Tn-specific isolectin B4 from Vicia villosa. FEBS Letters, Wiley, 1997, 412 (1), pp.190-196. ⟨10.1016/s0014-5793(97)00677-7⟩. ⟨pasteur-03136637⟩

Preprints, Working Papers, ...2 documents

  • Jules Lavalou, Qiyan Mao, Stefan Harmansa, Stephen Kerridge, Annemarie Lellouch, et al.. Formation of polarized contractile interfaces by self-organized Toll-8/Cirl GPCR asymmetry. 2021. ⟨hal-03100930⟩
  • Lara Lee, Ana Belen Perez Oliva, Dmitri Churikov, Elena Martinez-Balsalobre, Joshua Peter, et al.. UFMylation of MRE11 is essential for maintenance of telomere length and hematopoietic stem cell survival. 2020. ⟨hal-03020992⟩